Cyclophosphamide

Sarcoma,Soft Tissue

St. Jude Children's Research HospitalSmall moleculePhase 2Active

BB

67/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 52/ 100
Competitive Position: 95/ 100

Competitive context

103 Active assets in the Sarcoma,Soft Tissue cohort.

Asset / Sponsor	Phase	Rating
Palbociclib Brown University	Phase 2	BB
Eloxatin OHSU Knight Cancer Institute	Phase 2	BB
Inno-206 GI Innovation, Inc.	Phase 3	BB
FILGRASTIM University of California, Irvine	Phase 3	BB
Inno-206 Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Phase 3	BB

View all 50 →

Same molecule, other indications

Cyclophosphamide is also rated in:

adult acute lymphoblastic leukemiaDormant

BBB

Indicative ·

79 / 100

mycosis fungoidesDormant

BBB

Indicative ·

78 / 100

B-cell childhood acute lymphoblastic leukemiaDormant

BBB

Indicative ·

78 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.